Psoriatic Arthritis and Psoriasis Treatment Decision Aid

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to create and test a patient decision aid that facilitates the shared decision-making process when patients with psoriasis and/or psoriatic arthritis are starting or switching to a new therapy.

Detailed Description
-----------------
Prior to the interventional study, we will develop a decision aid using design thinking. In this interventional study, we will implement and test a patient-centered decision aid for therapy selection among patients with psoriasis and/or psoriatic arthritis who are starting or switching to a new medication.

Official Title
-----------------
Developing a Patient-centered Patient Decision Aid for Psoriasis and/or Psoriatic Arthritis Using Design Thinking.

Conditions
-----------------
Psoriatic Arthritis, Psoriasis

Intervention / Treatment
-----------------
* Other: Decision Aid


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age 18 years or older Diagnosis of psoriasis (as confirmed by dermatologist) or psoriatic arthritis (as confirmed by rheumatologist) Treated at Penn In addition to the above, for the observation and implementation phases of the study: Initiation of a new psoriasis or psoriatic arthritis treatment Biosimilars that have been approved by the FDA and available on the US market will similarly be eligible for participation Patients may be taking other traditional DMARDs. A washout period is not required. Exclusion Criteria: Unable to give informed consent Youth, under the age of 18 years Patients without psoriasis or psoriatic arthritis Not being treated at a Penn clinic In addition to the above, for the observation and implementation phases of the study: Not starting or switching to a new medication

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Interventional Model Description: Patients and providers will use a web-based or paper decision aid. They will not be assigned to specific arms or undergo randomized treatment.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Decision Aid Testing<br>Participants will have the opportunity to test the different decision aid prototypes while selecting new treatment/therapy. | Other: Decision Aid<br>* Participants will test decision aid prototypes that are designed to assist them in choosing a medication.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient and provider self-reported perceptions of the decision aid as measured by satisfaction survey | Satisfaction survey to rate the decision aid and shared decision-making process | Up to 24 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of times decision aid was used in consultation for patients switching therapies or starting a new treatment. | Rates of of the decision aid use | Up to 24 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Decision Aid, Shared Decision-Making